A case of acute kidney injury secondary to black cherry concentrate in a patient with chronic kidney disease secondary to type 2 diabetes mellitus
- 23 Downloads
There are many herbal products which are accessible to patients, and they may provide with many health benefits. Nevertheless, some of these supplements can lead to significant morbidity as they can also have important side effects and impact patient’s organ systems. In this case report, we present a patient with chronic kidney disease secondary to type II diabetes mellitus who develops acute kidney injury and metabolic disturbances secondary to consuming black cherry concentrate as a mean to self-manage his gout flare. The most likely mechanism of injury was cyclooxygenase inhibition by anthocyanins, molecular compounds found in cherries that have a similar mechanism of action to nonsteroidal anti-inflammatory medications. Patient’s kidney injury and metabolic disturbances improved after the discontinuation of black cherry concentrate. This is the second case report that presents a correlation between consumption of cherry concentrate in a patient with chronic kidney disease and acute kidney injury.
KeywordsAcute kidney injury Herbal medicine Chronic kidney disease Anthocyanins
- 1.ONTARGET. Investigators Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. U.S. National Library of Medicine. 2008. Retrieved December 10, 2017, from https://www.ncbi.nlm.nih.gov/pubmed/18378520
- 4.Blau LW. Cherry diet control for gout and arthritis. Tex Rep Biol Med. 1950;8:309–11.Google Scholar
- 9.Mulabagal V, et al. Anthocyanin content, lipid peroxidation and cyclooxygenase enzyme inhibitory activities of sweet and sour cherries. J Agric Food Chem (U.S. National Library of Medicine). 2009. Retrieved December 10, 2017 from https://www.ncbi.nlm.nih.gov/pubmed/19199585.
- 10.Seeram NP, et al. Cyclooxygenase inhibitory and antioxidant cyanidin glycosides in cherries and berries. Phytomedicine (U.S. National Library of Medicine). 2001. Retrieved December 12, 2017 from https://www.ncbi.nlm.nih.gov/pubmed/11695879.
- 12.Firestein GS. Mechanisms of inflammation and tissue repair. Goldmans Cecil Med (Elsevier BV). 2012. https://doi.org/10.1016/2Fb978-1-4377-1604-7.00047-6.
- 14.Tulunay FC. NSAIDs: behind the mechanisms of action. Funct Neurol. 2000;15(Suppl 3):202–7.Google Scholar
- 16.Walls, R. M., Hockberger, R. S., & Gausche-Hill, M. (2018). Aspirin and Nonsteroidal Agents. In: Rosens emergency medicine: Concepts and clinical practice. Philadelphia, PA: Elsevier.Google Scholar
- 17.McQuay HJ, Moore RA. NSAIDS and Coxibs: clinical use. In: Wall and Melzack's Textbook of Pain. Elsevier BV; 2006. p. 471–80.Google Scholar